Hepato Protect

Challenge

Low Dr. acceptance of a Worlds leading pharma company’s brand, & competition from ayurvedic.

Mandate

Grow sales by 15% from current 2% degrowth rates

Diagnostic strategies and recommendations

• Gastro’s the largest prescribers needed convincing on efficacy. Done by increased meets, sales team training and Key opinion leaders support
• Getting Dr.’s to prescribe for shorter duration to see results as  unnecessarily Dr. prescribing twin drug
• Increased scanning camps at Dr location to increase diagnosis and Dr support
• Targeted institutional business with meets & conferences in these hospitals
• Identified weaker region,  to be supported to build